Use of soluble fgl2 as an immunosuppressant

Details Use of soluble fgl2 as an immunosuppressant Use of soluble fgl2 as an immunosuppressant

2003-02-28

2009-12-15

Haddad, Maher M (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C424S184100, C530S300000

Reexamination Certificate

active

07632495

ABSTRACT:
Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a soluble fgl2 protein or a nucleic acid encoding a soluble fgl2 protein. The methods are useful in preventing graft rejection, autoimmune disease, and allergies.

REFERENCES:
patent: 5254339 (1993-10-01), Morein
patent: 6403089 (2002-06-01), Levy et al.
patent: 2006/0078550 (2006-04-01), Levy et al.
patent: WO 98/51335 (1998-11-01), None
Feldmann et al. Nature 2005, 435:612-619.
Bach et al. Transplantation Immunology 1995, published by Wiley-Liss, Inc. Chapter 7, pp. 142-145.
Kahan. Cur. Opin. Immunol., 1992; 4:553-560.
Tufveson et al. Immunological Reviews, 1993; 136:99-109.
Camie et al. The Journal of Immunology. 2003; 170:4036-4044.
Liu et al. Eur. J. Immunol. 2008. 38:1-14. Copy is not provided.
Sakaguchi et al. Nat. Immunol. 2005 Apr; 6(4):345-352.
Chan, C.W.Y. et al., The Journal of Immunology, vol. 170. No. 8, pp. 4036-4044, Apr. 2003.
Ruegg, C et al., Gene, vol. 160, No. 2, pp. 257-262, Jul. 1995.
Chan, C.W.Y. et al., The Journal of Immunology, vol. 168. No. 10, pp. 5170-5177, May 2002.
Marazzi, S. et al, The Journal of Immunology, vol. 161, No. 1, pp. 138-147, Jul. 1998.
Koyama, T et al., Proceedings of the National Academy of Sciences, vol. 84, No. 84, pp. 1609-1613, Mar. 1987.
Yuwaraj, S et al., Genomics, vol. 71, No. 3, pp. 330-338, Feb. 2001.
Levy, G.A. et al., American Journal of Pathology, vol. 156, No. 4, pp. 1217-1225, Apr. 2000.

Affiliated with

Also associated with

Rating

Use of soluble fgl2 as an immunosuppressant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of soluble fgl2 as an immunosuppressant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of soluble fgl2 as an immunosuppressant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4145901